These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 4030021

  • 1. [Alopecia areata and treatment with the diethylester of squaric acid. Behavior of lymphocyte subpopulations].
    Pigatto PD, Gini R, Altomare GF.
    G Ital Dermatol Venereol; 1985; 120(3):227-30. PubMed ID: 4030021
    [No Abstract] [Full Text] [Related]

  • 2. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
    Rosso R, Paulli M, Marelli MA, Douville H, Orecchia G.
    G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
    [No Abstract] [Full Text] [Related]

  • 3. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
    Pigatto PD, Rapisarda R, Polenghi MM, Altomare GF.
    G Ital Dermatol Venereol; 1987 Dec; 122(12):667-70. PubMed ID: 3329149
    [No Abstract] [Full Text] [Related]

  • 4. Topical squaric acid dibutylester therapy for alopecia areata.
    Flowers FP, Slazinski L, Fenske NA, Pullara TJ.
    Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
    [No Abstract] [Full Text] [Related]

  • 5. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A, Mato F, Quiñones PA.
    Med Cutan Ibero Lat Am; 1984 Dec; 12(3):273-8. PubMed ID: 6384701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND, Bunata K, Hebert AA.
    Clin Dermatol; 2015 Dec; 33(3):300-4. PubMed ID: 25889130
    [Abstract] [Full Text] [Related]

  • 11. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT.
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [Abstract] [Full Text] [Related]

  • 12. Treatment of alopecia areata with topical sensitizers.
    Sutherland L, Laschinger M, Syed ZU, Gaspari A.
    Dermatitis; 2015 Mar; 26(1):26-31. PubMed ID: 25581667
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K, Fukushima S, Mizuhashi S, Jinnin M, Makino T, Inoue Y, Ihn H.
    Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin DJ.
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
    Giannetti A, Orecchia G.
    Dermatologica; 1983 Aug; 167(5):280-2. PubMed ID: 6653853
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y, Hatamochi A, Hamasaki Y, Suzuki H, Ikeda H, Yamazaki S.
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.